Overview

Non-Nicotine Agents for Smoking Cessation

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.
Phase:
Phase 3
Details
Lead Sponsor:
US Department of Veterans Affairs
VA Office of Research and Development
Treatments:
Bupropion
Nicotine